Tomato Fruit Extract
Hypertension,Essential
Beata KrasinskaPhase 4 / ApprovedDormant
BB
69/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 54/ 100
- Competitive Position
- 95/ 100
Competitive context
17 Active assets in the Hypertension,Essential cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Hydrochlorothiazide Yuhan Corporation | Phase 4 | BBB |
AMLODIPINE Yuhan Corporation | Phase 4 | BBB |
Phentermine VIVUS LLC | Phase 4 | BB |
VALSARTAN ARKAY Therapeutics | Phase 4 | BB |
LABETALOL ProMedica Health System | Phase 3 | BB |
View all 44 →
Same molecule, other indications
Tomato Fruit Extract is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →